Genetic Variants and Mortality After Acute Coronary Syndrome
Author Information
Author(s): Morgan Thomas M, Xiao Lan, Lyons Patrick, Kassebaum Bethany, Krumholz Harlan M, Spertus John A
Primary Institution: Vanderbilt University School of Medicine
Hypothesis
Do candidate gene variants affect all-cause mortality following acute coronary syndrome?
Conclusion
The study found that most candidate genes were not associated with post-ACS mortality, except for the IRS1 variant which showed borderline significance.
Supporting Evidence
- 16 out of 89 genetic variants were potentially associated with mortality.
- 6 variants were significantly associated with mortality at p<0.05.
- The IRS1 Gly972Arg variant showed a strong association with mortality.
Takeaway
The researchers looked at genes to see if they could predict who might die after a heart problem, but they mostly found that these genes didn't help much.
Methodology
The study genotyped 89 genetic variants in 811 ACS survivors and performed survival analyses and Cox regression.
Potential Biases
Potential bias from focusing on a single racial group and the small sample size may limit generalizability.
Limitations
The study had limited power due to a small number of deaths and focused only on white patients.
Participant Demographics
811 self-reported white patients of European ancestry with acute coronary syndrome.
Statistical Information
P-Value
P = 0.001 for IRS1 variant
Confidence Interval
0.02, 0.84 for A/G and 0.05, 0.99 for G/G genotypes of IRS1
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website